Literature DB >> 25115981

[Uncommon clinical manifestations of cutaneous leishmaniasis].

K Hayani1, A Dandashli, E Weisshaar.   

Abstract

Cutaneous leishmaniasis is one of the most common dermatoses of the tropics. A major focus of this disease is the Syrian city of Aleppo, after which it was named in many textbooks ("Aleppo boil"). The first cases of cutaneous leishmaniasis were reported from Aleppo particularly more than 100 years ago. Syria is one of the most affected countries worldwide. This disease used to be well documented until the onset of the war in Syria in 2012, which is also supported by the numbers of the World Health Organisation (WHO), and Aleppo used to be the most affected Syrian city. Since 2012, the documentation of cutaneous leishmaniasis in Syria is no longer possible. An outbreak of cutaneous leishmaniasis has been detected especially in the besieged regions due to missing prevention measures against the sandflies and a lack of medical care. A short summary of the epidemiologic situation in Syria as well as outstanding and uncommon clinical manifestations of cutaneous leishmaniasis in Aleppo are presented.

Entities:  

Mesh:

Year:  2014        PMID: 25115981     DOI: 10.1007/s00105-014-2802-7

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  24 in total

1.  Isoenzyme characterization of Leishmania isolates from Lebanon and Syria.

Authors:  K N Knio; E Baydoun; R Tawk; N Nuwayri-Salti
Journal:  Am J Trop Med Hyg       Date:  2000 Jul-Aug       Impact factor: 2.345

2.  A randomized, double-blind study of the efficacy of a 10- or 20-day course of sodium stibogluconate for treatment of cutaneous leishmaniasis in United States military personnel.

Authors:  Glenn Wortmann; R Scott Miller; Charles Oster; Joan Jackson; Naomi Aronson
Journal:  Clin Infect Dis       Date:  2002-07-10       Impact factor: 9.079

3.  Transient effect of topical treatment of cutaneous leishmaniasis with imiquimod.

Authors:  Josef Seeberger; Saleh Daoud; Johannes Pammer
Journal:  Int J Dermatol       Date:  2003-07       Impact factor: 2.736

4.  [A new zymodeme of Leishmania tropica, agent of Aleppo boil (Syria)].

Authors:  S Belazzoug; F Pratlong; J A Rioux
Journal:  Arch Inst Pasteur Alger       Date:  1988

5.  Twenty years of cutaneous leishmaniasis in Aleppo, Syria.

Authors:  A Tayeh; L Jalouk; S Cairncross
Journal:  Trans R Soc Trop Med Hyg       Date:  1997 Nov-Dec       Impact factor: 2.184

6.  Visceral leishmaniasis in the Syrian Arab Republic: early detection using rK39.

Authors:  S Al-Nahhas; M Shabaan; L Hammoud; A Al-Taweel; S Al-Jorf
Journal:  East Mediterr Health J       Date:  2003-07       Impact factor: 1.628

7.  A randomized trial comparing a pentavalent antimonial drug and recombinant interferon-gamma in the local treatment of cutaneous leishmaniasis.

Authors:  G Harms; A K Chehade; M Douba; M Roepke; A Mouakeh; F Rosenkaimer; U Bienzle
Journal:  Trans R Soc Trop Med Hyg       Date:  1991 Mar-Apr       Impact factor: 2.184

Review 8.  Treatment of cutaneous leishmaniasis among travellers.

Authors:  J Blum; P Desjeux; E Schwartz; B Beck; C Hatz
Journal:  J Antimicrob Chemother       Date:  2004-01-16       Impact factor: 5.790

9.  The psychological impact of cutaneous leishmaniasis.

Authors:  M Yanik; M S Gurel; Z Simsek; M Kati
Journal:  Clin Exp Dermatol       Date:  2004-09       Impact factor: 3.470

Review 10.  Leishmaniasis: current situation and new perspectives.

Authors:  P Desjeux
Journal:  Comp Immunol Microbiol Infect Dis       Date:  2004-09       Impact factor: 2.268

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.